FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-5624 | 26436-5624-1 | Tetracaine; Lidocaine; Phenylephrine Hydrochloride | 70 mg/1 g; 200 mg/1 g; 5 mg/1 g | 2025-1 | valid | 2026-10-21 | |
| Hybrid Pharma | 26436-5624 | 26436-5624-1 | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 20%/7%/0.5% | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 20/7/0.5 | 70 mg/1 g; 200 mg/1 g; 5 mg/1 g | 2025-1 | valid | 2026-09-18 | |
| Hybrid Pharma | 079665742 | 26436-5624 | 26436-5624-1 | Tetracaine; Lidocaine; Phenylephrine Hydrochloride | 70 mg/1 g; 200 mg/1 g; 5 mg/1 g | 2024-2 | valid | 2026-10-21 | |
| Hybrid Pharma | 26436-5624 | 26436-5624-1 | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 20%/7%/0.5% | LIDOCAINE/TETRACAINE/ PHENYLEPHRINE HCL 20/7/0.5 | 70 mg/1 g; 200 mg/1 g; 5 mg/1 g | 2024-2 | valid | 2026-09-18 |